To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
59 Current news from russian federation
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes
15-Dec-2011
Evolva Holding SA announced that the Russian Patent Office has granted patent protection for EV-077 in the treatment of complications of diabetes for a term extending to 2026. This is the first patent granted covering EV-077. EV-077 patent applications are currently pending in Australia, Brazil, ...
Evonik establishes joint venture in Russia to produce feed amino acid L-lysine
Growing demand for biotechnology-manufactured L-lysine in Russia
05-Oct-2011
Evonik Industries and Russian company RusBiotech International have established the joint venture Russkie Biotechnologii for manufacturing L-lysine in Russia by means of a biotechnological process. Vassily Golubev, governor of the Rostov-on-Don region, and Vadim Varshavsky, a deputy of the State ...
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia
Facility expected to be complete by 2014, planned to manufacture pharmaceuticals and high-quality generics
20-Jun-2011
Novartis held a groundbreaking ceremony to announce the start of construction of a pharmaceutical manufacturing plant in St. Petersburg, Russia. The construction of this facility represents the most significant Novartis investment in Russia to date. This facility will further expand the company's ...
Pharmsynthez granted Orphan Drug Designation for Virexxa in the US
01-Mar-2011
Pharmsynthez announced that the United States Food and Drug Administration (FDA) has unanimously awarded Virexxa, OJSC Pharmsynthez’s treatment for hormonotherapy-resistant endometrial cancer (a malignant tumor of the female reproductive system), orphan drug designation.Virexxa is the first ...
M+W Group is to set up a biotechnology plant in Siberia
05-Nov-2010
M+W Group has signed a letter of intent for design and construction of a biotechnology plant complex in the Siberian town of Omsk. This was announced at the German-Russian raw materials forum taking place in Moscow. Contracting partner of M+W Group are the governor of Omsk, Mr. Leonid K. ...
Novartis announces Russian regulatory approval for Gilenya, a once-daily oral multiple sclerosis therapy
13-Sep-2010
The Russian health authority, the Federal Service on Surveillance in Healthcare and Social Development, has granted approval for Gilenya® (fingolimod) 0.5 mg once-daily oral therapy for the treatment of relapsing remitting multiple sclerosis (MS). Approximately 85% of patients with MS are ...
Scientists identify virulent new strains of Ug99 stem rust
Wheat experts report progress toward replacing 5 percent of vulnerable fields in nations at risk
28-May-2010
Four new mutations of Ug99, a strain of a deadly wheat pathogen known as stem rust, have overcome existing sources of genetic resistance developed to safeguard the world's wheat crop. Leading wheat experts from Australia, Asia, Africa, Europe and the Americas, who are in St. Petersburg, Russia ...
Affitech Signs Strategic Alliance with Russian Biotech Partner
23-Apr-2010
NauchTekhStroy Plus (NTS Plus), a newly formed joint venture subsidiary of Pharmstandard will conduct clinical development and registration of two Affitech antibodies for Russian and CIS markets. NTS Plus will pay €23 million in fees and advanced royalties to Affitech. Pharmstandard will ...
OPK Biotech Develops Research and Production in Russia
12-Oct-2009
Biopure Corporation was finally taken under OPK Biotech's control, a part of the United Industrial Corporation (OPK). OPK Biotech has high-qualified specialists and managers in the domain of biochemistry and finance. All top-managers possess academic degrees and scientific education from leading ...
